Los Angeles, CA: A jury has awarded $18.5 million against Boston Scientific Corp in settlement of transvaginal mesh litigation brought by four women who alleged the implanted medical device left them with nerve damage, infections and pain during sex.
The trial was heard by a federal jury in West Virginia and is the second verdict against the company over defective vaginal slings. Last week a federal jury in Florida issued a $26.7 million verdict against Boston Scientific for providing insufficient warnings about the risks of its Pinnacle mesh device.
The four women in the West Virginia case sued Boston Scientific over the defective Obtryx transvaginal sling. "In these cases, the jurors clearly understood that Boston Scientific moved too quickly in bringing its product to market, and that it used inappropriate materials while at the same time failing to warn doctors and patients about the risks involved,"said on the of the lawyers representing the plaintiffs. Each of the women will receive $1 million in punitive damages under the terms of the settlement.
The multidistrict litigation being heard in Miami, also involved four women who alleged suffering and injury after having the sling implanted. It was the first federal bellwether trial against Boston Scientific, one of seven manufacturers of pelvic mesh that face about 60,000 lawsuits across the country.
Transvaginal Mesh and Transvaginal Slings are medical devices that are surgically implanted to treat Pelvic Organ Prolapse (POP) and/or Stress Urinary Incontinence(SUI). Earlier this week a California appeals court upheld a $5.5 million award in the first jury verdict against pelvic mesh device manufacturer C.R. Bard Inc.